FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * KLISARES PETE A   2. Issuer Name and Ticker or Trading Symbol VISTACARE, INC. [VSTA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O VISTACARE, INC., 4800 N. SCOTTSDALE RD., SUITE 5000 3. Date of Earliest Transaction (Month/Day/Year) 02/29/2008 (Street) SCOTTSDALE, AZ 85251 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock               2,000 D   Class A Common Stock               7,000 D   Class A Common Stock 02/29/2008 02/29/2008 U   2,000 (1) D $ 8.6 5,000 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option (right to buy)

$ 12.5

11/11/2002

11/11/2012

Class A Common Stock

10,000

10,000

D

Stock Option (right to buy)

$ 34.09

02/10/2004

02/10/2014

Class A Common Stock

20,000

30,000

D

Stock Option (right to buy)

$ 17.51

05/04/2005

05/04/2015

Class A Common Stock

10,000

40,000

D

Stock Option (right to buy)

$ 17.58

05/05/2005

05/05/2015

Class A Common Stock

10,000

50,000

D

Stock Option (right to buy)

$ 13.62

05/17/2006

05/17/2016

Class A Common Stock

20,000

70,000

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
KLISARES PETE A C/O VISTACARE, INC. 4800 N. SCOTTSDALE RD., SUITE 5000 SCOTTSDALE, AZ 85251	X

Signatures

Stephen Lewis, Attorney-in-Fact		02/29/2008
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	For tender of shares: Pursuant to the terms of an Agreement and Plan of Merger, dated as of January 15, 2008 (the "Merger Agreement"), by and among Odyssey HealthCare Holding Company ("Parent"), a Delaware corporation, OHC Investment, Inc. ("Purchaser"), a Delaware corporation and wholly-owned subsidiary of Parent, and the Issuer, Purchaser, on January 30, 2008, commenced a cash tender offer to purchase all of the Issuer's outstanding shares of class A common stock, par value $0.01 per share (the "Shares") at a price of $8.60 per Share (the "Offer Price"). Concurrently with the execution of the Merger Agreement, and as a condition of Parent's and Purchaser's willingness to enter into the Merger Agreement, the Reporting Person entered into a stockholder agreement with Parent and Purchaser, whereby, among other things, the Reporting Person agreed to tender all shares in the Issuer beneficially owned by the Reporting Person within three business days after the commencement of the tend

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.